Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof

an immunohistochemical and proteomics-based strategy.

Maria Kabbage, Mounir Trimeche, Hela Ben Nasr, Philippe Hammann, Lauriane Kuhn, Bechr Hamrita, Anouar Chaieb, Lotfi Chouchane, Karim Chahed

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

This study aims to evaluate αB-crystallin expression in infiltrating ductal breast carcinomas (IDCAs), as well as, its prognostic significance. Using a two-dimensional electrophoresis matrix-assisted laser desorption/ionisation-time of flight mass spectrometry investigation coupled to an immunohistochemical approach, we have assessed the expression of αB-crystallin in IDCAs, as well as, in other types of breast tumors (invasive lobular carcinomas, medullary carcinomas, and in situ ductal carcinomas). Correlation between αB-crystallin expression and clinicopathological parameters of breast cancer has also been investigated. Proteomic analyses revealed an increased expression of αB-crystallin in IDCA tumors compared to adjacent nontumor tissues. Overexpression of this molecular chaperone was further confirmed in 51 tumor specimens. Statistical analyses revealed, however, no significant correlations between αB-crystallin expression and clinicopathological parameters of the disease (tumor stage, patient age, hormone receptors, SBR grade, and lymph node metastases). This study demonstrates the upregulation of αB-crystallin in IDCA tissues which may highlight its possible involvement in breast cancer development. Our findings do not, however, support the involvement of this molecular chaperone in the progression of this disease.

Original languageEnglish
Pages (from-to)2279-2288
Number of pages10
JournalTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Volume33
Issue number6
Publication statusPublished - 1 Jan 2012

Fingerprint

Carcinoma, Ductal, Breast
Crystallins
Molecular Chaperones
Proteomics
Breast Neoplasms
Lobular Carcinoma
Ductal Carcinoma
Medullary Carcinoma
Carcinoma in Situ
Disease Progression
Electrophoresis
Mass Spectrometry
Neoplasms
Lasers
Up-Regulation
Lymph Nodes
Hormones
Neoplasm Metastasis

ASJC Scopus subject areas

  • Cancer Research

Cite this

Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof : an immunohistochemical and proteomics-based strategy. / Kabbage, Maria; Trimeche, Mounir; Ben Nasr, Hela; Hammann, Philippe; Kuhn, Lauriane; Hamrita, Bechr; Chaieb, Anouar; Chouchane, Lotfi; Chahed, Karim.

In: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, Vol. 33, No. 6, 01.01.2012, p. 2279-2288.

Research output: Contribution to journalArticle

@article{1cd23a7f83734da2a355ab2851ed2d6c,
title = "Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof: an immunohistochemical and proteomics-based strategy.",
abstract = "This study aims to evaluate αB-crystallin expression in infiltrating ductal breast carcinomas (IDCAs), as well as, its prognostic significance. Using a two-dimensional electrophoresis matrix-assisted laser desorption/ionisation-time of flight mass spectrometry investigation coupled to an immunohistochemical approach, we have assessed the expression of αB-crystallin in IDCAs, as well as, in other types of breast tumors (invasive lobular carcinomas, medullary carcinomas, and in situ ductal carcinomas). Correlation between αB-crystallin expression and clinicopathological parameters of breast cancer has also been investigated. Proteomic analyses revealed an increased expression of αB-crystallin in IDCA tumors compared to adjacent nontumor tissues. Overexpression of this molecular chaperone was further confirmed in 51 tumor specimens. Statistical analyses revealed, however, no significant correlations between αB-crystallin expression and clinicopathological parameters of the disease (tumor stage, patient age, hormone receptors, SBR grade, and lymph node metastases). This study demonstrates the upregulation of αB-crystallin in IDCA tissues which may highlight its possible involvement in breast cancer development. Our findings do not, however, support the involvement of this molecular chaperone in the progression of this disease.",
author = "Maria Kabbage and Mounir Trimeche and {Ben Nasr}, Hela and Philippe Hammann and Lauriane Kuhn and Bechr Hamrita and Anouar Chaieb and Lotfi Chouchane and Karim Chahed",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "33",
pages = "2279--2288",
journal = "Tumor Biology",
issn = "1010-4283",
publisher = "Springer Netherlands",
number = "6",

}

TY - JOUR

T1 - Expression of the molecular chaperone αB-crystallin in infiltrating ductal breast carcinomas and the significance thereof

T2 - an immunohistochemical and proteomics-based strategy.

AU - Kabbage, Maria

AU - Trimeche, Mounir

AU - Ben Nasr, Hela

AU - Hammann, Philippe

AU - Kuhn, Lauriane

AU - Hamrita, Bechr

AU - Chaieb, Anouar

AU - Chouchane, Lotfi

AU - Chahed, Karim

PY - 2012/1/1

Y1 - 2012/1/1

N2 - This study aims to evaluate αB-crystallin expression in infiltrating ductal breast carcinomas (IDCAs), as well as, its prognostic significance. Using a two-dimensional electrophoresis matrix-assisted laser desorption/ionisation-time of flight mass spectrometry investigation coupled to an immunohistochemical approach, we have assessed the expression of αB-crystallin in IDCAs, as well as, in other types of breast tumors (invasive lobular carcinomas, medullary carcinomas, and in situ ductal carcinomas). Correlation between αB-crystallin expression and clinicopathological parameters of breast cancer has also been investigated. Proteomic analyses revealed an increased expression of αB-crystallin in IDCA tumors compared to adjacent nontumor tissues. Overexpression of this molecular chaperone was further confirmed in 51 tumor specimens. Statistical analyses revealed, however, no significant correlations between αB-crystallin expression and clinicopathological parameters of the disease (tumor stage, patient age, hormone receptors, SBR grade, and lymph node metastases). This study demonstrates the upregulation of αB-crystallin in IDCA tissues which may highlight its possible involvement in breast cancer development. Our findings do not, however, support the involvement of this molecular chaperone in the progression of this disease.

AB - This study aims to evaluate αB-crystallin expression in infiltrating ductal breast carcinomas (IDCAs), as well as, its prognostic significance. Using a two-dimensional electrophoresis matrix-assisted laser desorption/ionisation-time of flight mass spectrometry investigation coupled to an immunohistochemical approach, we have assessed the expression of αB-crystallin in IDCAs, as well as, in other types of breast tumors (invasive lobular carcinomas, medullary carcinomas, and in situ ductal carcinomas). Correlation between αB-crystallin expression and clinicopathological parameters of breast cancer has also been investigated. Proteomic analyses revealed an increased expression of αB-crystallin in IDCA tumors compared to adjacent nontumor tissues. Overexpression of this molecular chaperone was further confirmed in 51 tumor specimens. Statistical analyses revealed, however, no significant correlations between αB-crystallin expression and clinicopathological parameters of the disease (tumor stage, patient age, hormone receptors, SBR grade, and lymph node metastases). This study demonstrates the upregulation of αB-crystallin in IDCA tissues which may highlight its possible involvement in breast cancer development. Our findings do not, however, support the involvement of this molecular chaperone in the progression of this disease.

UR - http://www.scopus.com/inward/record.url?scp=85027936363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027936363&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 2279

EP - 2288

JO - Tumor Biology

JF - Tumor Biology

SN - 1010-4283

IS - 6

ER -